17:29 EDT C4 Therapeutics (CCCC) files to sell 4.87M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCCC:
- C4 Therapeutics reports Q3 EPS (35c), consensus (38c)
- C4 Therapeutics Appoints New Chief Scientific Officer
- C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
- C4 Therapeutics announces next steps for CFT1946
- C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial